Almaarefa University
The authoritative source for research information and outputs is Elsevier Scopus, with researcher profile verification from the Deanship of Scientific Research.

المخرجات

Research outputs

Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.

2 output Results for «Depigmentation»

ArticleOpen access2026

Vitiligo like depigmentation in a patient with NHEJ1 deficiency related radiosensitive SCID: A case report

JAAD Case Reports · vol. 73 · 106-110

Severe combined immunodeficiency (SCID) represents a group of life-threatening primary immunodeficiencies characterized by defective T and B-lymphocyte function, typically presenting with severe and recurrent infections during early infancy.1 A subgroup of them, referred to as radiosensitive SCID, results from defects within the nonhomologous end-joining (NHEJ) pathway, which plays a crucial role in DNA double-strand break repair during V(D)J recombination. The NHEJ1 gene encodes for Cernunnos/XLF, an NHEJ1 scaffolding protein that is vital for DNA end ligation during this form of repair.

vitiligo-like depigmentationsevere combined immunodeficiencynon-homologous end joiningDNA double-strand break repair
ReviewOpen access202526citation· Semantic Scholar

Exploring the Safety and Efficacy of Glutathione Supplementation for Skin Lightening: A Narrative Review

Cureus · vol. 17 (1) · e78045-e78045

The rising demand for skin-lightening products has brought glutathione, a tripeptide with antioxidant properties and melanogenesis-regulating effects, into focus as a potentially safer alternative to conventional agents. This narrative review aims to evaluate the efficacy and safety of oral, topical, and intravenous glutathione in skin-lightening therapies. Oral administration shows significant but variable decreases in melanin levels with limited side effects. Topical formulations provide good-level melanin reduction and skin texture improvement but with varying sustainability. Intravenous glutathione, although having rapid action, is associated with serious safety concerns like anaphylaxis and hepatotoxicity, further aggravated by a lack of standardized dosing protocols. Current evidence supports glutathione's potential as a depigmenting agent but underscores the need for rigorous, large-scale clinical trials to establish long-term safety, optimal dosing, and standardized applications. Until such data are available, clinicians and consumers should exercise caution to ensure safe and effective dermatological practices, particularly with intravenous use.

glutathioneskin lighteningdepigmentationmelanogenesis